Melissa C Caughey1, Laura R Loehr1, Nigel S Key1, Vimal K Derebail1, Rebecca F Gottesman1, Abhijit V Kshirsagar1, Megan L Grove1, Gerardo Heiss1. 1. From the Departments of Medicine (M.C.C., N.S.K., V.K.D., A.V.K.) and Epidemiology (M.C.C., L.R.L., G.H.), University of North Carolina at Chapel Hill; Department of Neurology, Johns Hopkins University School of Medicine; Baltimore, MD (R.F.G.); and School of Public Health, Human Genetics Center, The University of Texas Health Science Center, Houston (M.L.G.).
Abstract
BACKGROUND AND PURPOSE: Numerous case reports describe stroke in individuals with sickle cell trait (SCT) in the absence of traditional risk factors for cerebrovascular disease. To date, no prospective epidemiological studies have investigated this association. METHODS: A population-based sample of blacks (n=3497; mean age=54 years; female=62%) was followed from 1987 to 2011 in the Atherosclerosis Risk in Communities (ARIC) study, contributing a total of 65 371 person-years. Hazard ratios and incidence rate differences for ischemic stroke were estimated, contrasting SCT to homozygous hemoglobin A. Models were adjusted for age, sex, smoking, diabetes mellitus, hypertension, total cholesterol, atrial fibrillation, and coronary heart disease. RESULTS: SCT was identified in 223 (6.4%) participants. During a median follow-up of 22 years, 401 subjects experienced incident stroke (89% ischemic). Incident ischemic stroke was more frequent among those with SCT (13%) than those with homozygous hemoglobin A (10%). SCT was associated with an ischemic stroke hazard ratio of 1.4 (1.0-2.0) and an incidence rate difference amounting to 1.9 (0.4-3.8) extra strokes per 1000 person-years. CONCLUSIONS: We observed an increased risk of ischemic stroke in blacks with SCT. Further investigation of the incidence and pathophysiology of stroke in patients with SCT is warranted.
BACKGROUND AND PURPOSE: Numerous case reports describe stroke in individuals with sickle cell trait (SCT) in the absence of traditional risk factors for cerebrovascular disease. To date, no prospective epidemiological studies have investigated this association. METHODS: A population-based sample of blacks (n=3497; mean age=54 years; female=62%) was followed from 1987 to 2011 in the Atherosclerosis Risk in Communities (ARIC) study, contributing a total of 65 371 person-years. Hazard ratios and incidence rate differences for ischemic stroke were estimated, contrasting SCT to homozygous hemoglobin A. Models were adjusted for age, sex, smoking, diabetes mellitus, hypertension, total cholesterol, atrial fibrillation, and coronary heart disease. RESULTS: SCT was identified in 223 (6.4%) participants. During a median follow-up of 22 years, 401 subjects experienced incident stroke (89% ischemic). Incident ischemic stroke was more frequent among those with SCT (13%) than those with homozygous hemoglobin A (10%). SCT was associated with an ischemic stroke hazard ratio of 1.4 (1.0-2.0) and an incidence rate difference amounting to 1.9 (0.4-3.8) extra strokes per 1000 person-years. CONCLUSIONS: We observed an increased risk of ischemic stroke in blacks with SCT. Further investigation of the incidence and pathophysiology of stroke in patients with SCT is warranted.
Authors: M P Westerman; D Green; A Gilman-Sachs; K Beaman; S Freels; L Boggio; S Allen; R Schlegel; P Williamson Journal: Am J Hematol Date: 2002-02 Impact factor: 10.047
Authors: R Grant Steen; Gisele M Hankins; Xiaoping Xiong; Winfred C Wang; Kenneth Beil; James W Langston; Kathleen J Helton Journal: Radiology Date: 2003-05-20 Impact factor: 11.105
Authors: Brett Kissela; Alexander Schneider; Dawn Kleindorfer; Jane Khoury; Rosemary Miller; Kathleen Alwell; Daniel Woo; Jerzy Szaflarski; James Gebel; Charles Moomaw; Arthur Pancioli; Edward Jauch; Rakesh Shukla; Joseph Broderick Journal: Stroke Date: 2004-02 Impact factor: 7.914
Authors: Melissa C Caughey; Vimal K Derebail; Nigel S Key; Alexander P Reiner; Rebecca F Gottesman; Abhijit V Kshirsagar; Gerardo Heiss Journal: Am J Hematol Date: 2019-09-10 Impact factor: 10.047
Authors: Lindsay Fernández-Rhodes; Kristin L Young; Adam G Lilly; Laura M Raffield; Heather M Highland; Genevieve L Wojcik; Cary Agler; Shelly-Ann M Love; Samson Okello; Lauren E Petty; Mariaelisa Graff; Jennifer E Below; Kimon Divaris; Kari E North Journal: Circ Res Date: 2020-06-04 Impact factor: 17.367
Authors: Natalie A Bello; Hyacinth I Hyacinth; Nicholas S Roetker; Samantha R Seals; Rakhi P Naik; Vimal K Derebail; Abhijit V Kshirsagar; Nigel S Key; James G Wilson; Adolfo Correa; Robert J Adams; Leonard D Egede; W T Longstreth; Gaurav Choudhary; Beatrice E Gee; Austin L Hughes; Amil M Shah; JoAnn E Manson; Matthew Allison; Gregory L Burke; Aaron R Folsom; Cara L Carty; Alexander P Reiner; Scott D Solomon; Suma H Konety Journal: Blood Date: 2016-12-08 Impact factor: 22.113
Authors: Mary Anne McDonald; Melissa S Creary; Jill Powell; Lori-Ann Daley; Charlotte Baker; Charmaine Dm Royal Journal: J Genet Couns Date: 2017-06-03 Impact factor: 2.537
Authors: Caroline K Thoreson; Michelle Y O'Connor; Madia Ricks; Stephanie T Chung; Anne E Sumner Journal: J Racial Ethn Health Disparities Date: 2015-09
Authors: Rakhi P Naik; Kim Smith-Whitley; Kathryn L Hassell; Nkeiruka I Umeh; Mariane de Montalembert; Puneet Sahota; Carlton Haywood; Jean Jenkins; Michele A Lloyd-Puryear; Clinton H Joiner; Vence L Bonham; Gregory J Kato Journal: Ann Intern Med Date: 2018-10-30 Impact factor: 25.391
Authors: Hyacinth I Hyacinth; Cara L Carty; Samantha R Seals; Marguerite R Irvin; Rakhi P Naik; Gregory L Burke; Neil A Zakai; James G Wilson; Nora Franceschini; Cheryl A Winkler; Victor A David; Jeffrey B Kopp; Suzanne E Judd; Robert J Adams; W T Longstreth; Leonard Egede; Daniel T Lackland; Herman Taylor; JoAnn E Manson; Virginia Howard; Matthew Allison; Beatrice E Gee; Adolfo Correa; Monika M Safford; Donna K Arnett; George Howard; Alexander P Reiner; Mary Cushman Journal: JAMA Neurol Date: 2018-07-01 Impact factor: 18.302